Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
yFMT Combined With Immunotherapy and Chemotherapy in MSS mCRC
NCT07486492Phase 1Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Mar 2026
- Primary completion
- Jan 2028
01
Overview
Phase 1, open-label, single-arm trial in colorectal cancer (CRC), sponsored by First Affiliated Hospital of Xiamen University. Primary endpoints: Serious Adverse Events at 12 months, Treatment-Related Adverse Events at 12 months and 1 more. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07486492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07486492.